Video: All Recombinant Proteins Are Not the Same

Bio-Techne presented expertise on recombinant protein selection and customization, including site-specific Avi-tag biotinylation and applications for biotinylated proteins in research. The webinar also featured information on COVID-19 SARS proteins available through Bio-Techne for coronavirus research and drug discovery applications.
Scientist.com
公開日
August 21, 2020

In mid-August, the Bio-Techne team shared their vast industry expertise in a webinar focusing on recombinant protein selection, customization and application.

The featured panelists — Bio-Techne’s Martin Ramsden, Director Commercial Development and John Humphrey, Director Molecular and Cellular Biology — presented on recombinant protein applications, specifically biotinylated proteins, including site-specific Avi-tag biotinylation. Humphrey also spoke at length about COVID-19 SARS proteins available through Bio-Techne.

Below is the recording of the full live webinar and Q&A session.

If you have questions for Bio-Techne or R&D Systems, you can email them at info@bio-techne.com or access their supplier page on Scientist.com .

Interested in hosting a webinar with Scientist.com? Contact us at marketing@scientist.com .

Abstract molecular cluster with three connected blue-green spheres on a white background.

次のステップへ進む

1
2
3

Explore Suppliers

関連する専門知識を持つ信頼できるパートナーを探す

Review Capabilities

サービス、経験、実績を比較する

Start Your Project

つながり、協業を始める

執筆者
Scientist.com
この記事をシェアする

続きを読む

続きを読む